Early treatment to prevent progression of SARS-CoV-2 infection

被引:11
作者
Cohen, Myron S. [1 ]
机构
[1] Univ N Carolina, Inst Global Hlth & Infect Dis, Bioinformat, Chapel Hill, NC 27517 USA
基金
美国国家卫生研究院;
关键词
D O I
10.1016/S2213-2600(22)00213-2
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
引用
收藏
页码:930 / 931
页数:2
相关论文
共 11 条
[1]   Molnupiravir for Oral Treatment of Covid-19 in Nonhospitalized Patients [J].
Bernal, A. Jayk ;
da Silva, M. M. Gomes ;
Musungaie, D. B. ;
Kovalchuk, E. ;
Gonzalez, A. ;
Delos Reyes, V ;
Martin-Quiros, A. ;
Caraco, Y. ;
Williams-Diaz, A. ;
Brown, M. L. ;
Du, J. ;
Pedley, A. ;
Assaid, C. ;
Strizki, J. ;
Grobler, J. A. ;
Shamsuddin, H. H. ;
Tipping, R. ;
Wan, H. ;
Paschke, A. ;
Butterton, J. R. ;
Johnson, M. G. ;
De Anda, C. .
NEW ENGLAND JOURNAL OF MEDICINE, 2022, 386 (06) :509-520
[2]  
Case JB, 2022, bioRxiv, DOI [10.1101/2022.03.17.484787, 10.1101/2022.03.17.484787, DOI 10.1101/2022.03.17.484787]
[3]  
Centers for Disease Control and Prevention, purported urban subculture that emerged from marginalized economic conditions
[4]   Oral Nirmatrelvir for High-Risk, Nonhospitalized Adults with Covid-19 [J].
Hammond, Jennifer ;
Leister-Tebbe, Heidi ;
Gardner, Annie ;
Abreu, Paula ;
Bao, Weihang ;
Wisemandle, Wayne ;
Baniecki, MaryLynn ;
Hendrick, Victoria M. ;
Damle, Bharat ;
Simon-Campos, Abraham ;
Pypstra, Rienk ;
Rusnak, James M. .
NEW ENGLAND JOURNAL OF MEDICINE, 2022, 386 (15) :1397-1408
[5]  
Johns Hopkins University, about us
[6]   ORIGINAL RESEARCH Underlying Medical Conditions and Severe Illness Among 540,667 Adults Hospitalized With COVID-19, March 2020-March 2021 [J].
Kompaniyets, Lyudmyla ;
Pennington, Audrey F. ;
Goodman, Alyson B. ;
Rosenblum, Hannah G. ;
Belay, Brook ;
Ko, Jean Y. ;
Chevinsky, Jennifer R. ;
Schieber, Lyna Z. ;
Summers, April D. ;
Lavery, Amy M. ;
Preston, Leigh Ellyn ;
Danielson, Melissa L. ;
Cui, Zhaohui ;
Namulanda, Gonza ;
Yusuf, Hussain ;
Mac Kenzie, William R. ;
Wong, Karen K. ;
Baggs, James ;
Boehmer, Tegan K. ;
Gundlapalli, Adi V. .
PREVENTING CHRONIC DISEASE, 2021, 18
[7]   Intramuscular AZD7442 (Tixagevimab-Cilgavimab) for Prevention of Covid-19 [J].
Levin, Myron J. ;
Ustianowski, Andrew ;
De Wit, Stephane ;
Launay, Odile ;
Avila, Miles ;
Templeton, Alison ;
Yuan, Yuan ;
Seegobin, Seth ;
Ellery, Adam ;
Levinson, Dennis J. ;
Ambery, Philip ;
Arends, Rosalinda H. ;
Beavon, Rohini ;
Dey, Kanika ;
Garbes, Pedro ;
Kelly, Elizabeth J. ;
Koh, Gavin C. K. W. ;
Near, Karen A. ;
Padilla, Kelly W. ;
Psachoulia, Konstantina ;
Sharbaugh, Audrey ;
Streicher, Katie ;
Pangalos, Menelas N. ;
Esser, Mark T. .
NEW ENGLAND JOURNAL OF MEDICINE, 2022, 386 (23) :2188-2200
[8]   Efficacy and safety of intramuscular administration of tixagevimab-cilgavimab for early outpatient treatment of COVID-19 (TACKLE): a phase 3, randomised, double-blind, placebo-controlled trial [J].
Montgomery, Hugh ;
Hobbs, F. D. Richard ;
Padilla, Francisco ;
Arbetter, Douglas ;
Templeton, Alison ;
Seegobin, Seth ;
Kim, Kenneth ;
Campos, Jesus Abraham Simon ;
Arends, Rosalinda H. ;
Brodek, Bryan H. ;
Brooks, Dennis ;
Garbes, Pedro ;
Jimenez, Julieta ;
Koh, Gavin C. K. W. ;
Padilla, Kelly W. ;
Streicher, Katie ;
Viani, Rolando M. ;
Alagappan, Vijay ;
Pangalos, Menelas N. ;
Esser, Mark T. .
LANCET RESPIRATORY MEDICINE, 2022, 10 (10) :985-996
[9]   A Novel Investigational Fc-Modified Humanized Monoclonal Antibody, Motavizumab-YTE, Has an Extended Half-Life in Healthy Adults [J].
Robbie, Gabriel J. ;
Criste, Ryan ;
Dall'Acqua, William F. ;
Jensen, Kathryn ;
Patel, Nita K. ;
Losonsky, Genevieve A. ;
Griffin, M. Pamela .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2013, 57 (12) :6147-6153
[10]  
US Food and Drug Administration, EM US AUTH EUA EVUSH